Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients

Parkinson’s disease (PD) is a progressive neurodegenerative disease, causing loss of motor and nonmotor function. Diagnosis is based on clinical symptoms that do not develop until late in the disease progression, at which point the majority of the patients’ dopaminergic neurons are already destroyed...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Chen, Honrao, Chandrashekhar, Rodrigues, Leonardo O., Wolf, Josephine, Sheehan, Keri B., Surface, Matthew, Alcalay, Roy N., O’Day, Elizabeth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876175/
https://www.ncbi.nlm.nih.gov/pubmed/35208223
http://dx.doi.org/10.3390/metabo12020149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876175/
https://www.ncbi.nlm.nih.gov/pubmed/35208223
http://dx.doi.org/10.3390/metabo12020149

Ejemplares similares